Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 267

Sort by

Sort Order Select

Journal Articles

MDS without clonal marker: When depth outperforms breadth

Sandra Huber, Wencke Walter, Marietta Truger, Stephan Hutter, Heiko Mueller, Torsten Haferlach, Manja Meggendorfer

Blood (2025) 146 (Supplement 1): 2071.

https://doi.org/10.1182/blood-2025-2071

Published: 2025

Journal Articles

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Blood (2025) 146 (Supplement 1): 2070.

https://doi.org/10.1182/blood-2025-2070

Published: 2025

Journal Articles

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

Blood (2025) 146 (Supplement 1): 2068.

https://doi.org/10.1182/blood-2025-2068

Published: 2025

Journal Articles

The PDI-ATF6-axis as a novel treatment target in CSF3R driven chronic neutrophilic leukemia (CNL)

Blood (2025) 146 (Supplement 1): 1453.

https://doi.org/10.1182/blood-2025-1453

Published: 2025

Journal Articles

Spatiotemporal and genetic tracking of long-term persisting CAR-T cells following ciltacabtagene autoleucel treatment for multiple myeloma reveals molecular insights into late-onset toxicities

Blood (2025) 146 (Supplement 1): 690.

https://doi.org/10.1182/blood-2025-690

Published: 2025

Journal Articles

CLL with t(11;14)(q13;q32) or t(14:18)(q32:q21) – is this CLL or lymphoma?

Alessandro Baldi, Wencke Walter, Anna Stengel, Heiko Mueller, Manja Meggendorfer, Isolde Summerer, Wolfgang Kern, Veronika Ecker

Blood (2025) 146 (Supplement 1): 2114.

https://doi.org/10.1182/blood-2025-2114

Published: 2025

Journal Articles

Activation of endogenous retroviral elements drives inflammation and transformation in STAG2-mutant myeloid malignancies

Johann-Christoph Jann, Ariel Swett, Yihua Wang, Rishika Vadlamudi, Benjamin Braun, Jennifer Karlow, Amy Wang, Lin Han, Griffin Lawrence, Caroline Pitton, Caroline Conway, Manja Meggendorfer, Karl Clauser, Steven A Carr, Jennifer Abelin, Torsten Haferlach, Kathleen Burns, Zuzana Tothova

Blood (2025) 146 (Supplement 1): 987.

https://doi.org/10.1182/blood-2025-987

Published: 2025

Journal Articles

Enrichment of rare pathogenic variants in common cancer predisposition genes in lymphatic malignancy: A comprehensive analysis of 2,138 cases

Lea Dewi Schlieben, Torsten Haferlach, Wolfgang Kern, Manja Meggendorfer, Armin Piehler

Blood (2025) 146 (Supplement 1): 1767.

https://doi.org/10.1182/blood-2025-1767

Published: 2025

Journal Articles

Determining the origin of TP53 mutations in patients with mature B-cell neoplasms is essential to distinguish lymphoma-related mutations from those due to clonal hematopoiesis, helping to guide treatment decisions

Veronika Ecker, Wencke Walter, Martha-Lena Mueller, Nicola Goetz, Christiane Eder, Manja Meggendorfer, Sandra Huber, Jana Wobst, Wolfgang Kern, Gregor Hoermann

Blood (2025) 146 (Supplement 1): 5389.

https://doi.org/10.1182/blood-2025-5389

Published: 2025

Journal Articles

Additional genetic targets are present in the majority of AML patients with NPM1, KMT2A or NUP98 aberrations potentially impacting combination therapy with menin inhibitors

Rainer Ordemann, Sandra Huber, Alessandro Baldi, Anna Stengel, Irene Fuhrmann, Christian Pohlkamp, Manja Meggendorfer, Sabit Delic, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann

Blood (2025) 146 (Supplement 1): 5248.

https://doi.org/10.1182/blood-2025-5248

Published: 2025

Journal Articles

Modeling of a hyper-inflammatory hematopoietic niche ex vivo reveals a multi-step process driving CAR T- cell associated myeloid leukemia in multiple myeloma

Blood (2025) 146 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2025-2152

Published: 2025

Journal Articles

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

Blood (2025) 146 (Supplement 1): 5785.

https://doi.org/10.1182/blood-2025-5785

Published: 2025

Journal Articles

The role of sole loss of chromosome y in myeloid neoplasms

Sandra Huber, Stephan Hutter, Manja Meggendorfer, Christian Pohlkamp, Torsten Haferlach, Isolde Summerer

Blood (2025) 146 (Supplement 1): 1390.

https://doi.org/10.1182/blood-2025-1390

Published: 2025

Journal Articles

Determining telomere content and genomics of myeloid neoplasia by whole-genome sequencing

Blood blood.2025028644.

https://doi.org/10.1182/blood.2025028644

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Molecular Aberrations on Discordance Among Modalities of Blast Enumeration for Risk Stratification in Myelodysplastic Neoplasms

Laurenz Steiner, Navkirandeep Kaur, Johann-Christoph Jann, Alice Fabarius, Georgia Metzgeroth, Manja Meggendorfer, Wolf-Karsten Hofmann, Mohamad Jawhar, Daniel Nowak, Alexander Streuer

Blood (2024) 144 (Supplement 1): 6724.

https://doi.org/10.1182/blood-2024-211446

Published: 2024

Journal Articles

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Anetta Marcinek, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2024-204966

Published: 2024

Journal Articles

Subtype Classification of BCP-ALL Dic(9;20)

Wencke Walter, Anna Stengel, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 5914.

https://doi.org/10.1182/blood-2024-204542

Published: 2024

Journal Articles

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

Claudia Haferlach, Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach

Blood (2024) 144 (Supplement 1): 1836.

https://doi.org/10.1182/blood-2024-201270

Published: 2024

Journal Articles

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

Blood (2024) 144 (Supplement 1): 666.

https://doi.org/10.1182/blood-2024-194405

Published: 2024

Journal Articles

A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)

Luca Lanino, Anthony M. Hunter, Nico Gagelmann, Marie Robin, Claudia Sala, Daniele Dall'Olio, Carmelo Gurnari, Lorenzo Dall'Olio, Yu-Hung Wang, Lisa Pleyer, Blanca Xicoy, Guillermo Montalban-Bravo, Lee-Yung Shih, Tamanna Haque, Omar Abdel-Wahab, Klaus Geissler, Alex Bataller, Alexandre Bazinet, Manja Meggendorfer, Ilaria Carola Casetti, Elisabetta Sauta, Erica Travaglino, Laura Palomo, Lurdes Zamora, David Quintela, Andres Jerez, Elena Cornejo, Paloma Garcia Martin, Marina Díaz-Beyá, Alejandro Avendaño Pita, Veronica Roldan, Dolly Viviana Fiallo Suarez, Estefania Cerezo Velasco, Marisa Calabuig, Esperanza Such, Guillermo Sanz, Anne Sophie Kubasch, Cristina Castilla-Llorente, Claude-Éric Bulabois, Laetitia Souchet, Hussein Awada, Massimo Bernardi, Patrizia Chiusolo, Antonio Curti, Luisa Giaccone, Francesco Onida, Lorenza Maria Borin, Francesco Passamonti, Elisa Diral, Vladan Vucinic, Gregorio Maria Bergonzi, Maria Teresa Voso, Hsin-An Hou, Wen-Chien Chou, Chi-Yuan Yao, Chien-Chin Lin, Hwei-Fang Tien, Alessia Campagna, Marta Ubezio, Antonio Russo, Gabriele Todisco, Giulia Maggioni, Cristina Astrid Tentori, Alessandro Buizza, Gianluca Asti, Matteo Zampini, Elena Riva, Mattia Delleani, Angela Consagra, Francesca Ficara, Armando Santoro, Luciana Carota, Tiziana Sanavia, Cesare Rollo, Ahmad Kiwan, Jennifer VanOudenhove, Piero Fariselli, Najla H. Al Ali, David Sallman, Wolfgang Kern, Guillermo Garcia-Manero, Swapna Thota, Elizabeth A. Griffiths, Matilde Yung Follo, Carlo Finelli, Uwe Platzbecker, Francesc Sole, Maria Diez-Campelo, Jaroslaw Maciejewski, Rafael Bejar, Felicitas R. Thol, Nicolaus Kröger, Pierre Fenaux, Raphael Itzykson, Timothy Aaron Graubert, Michaela Fontenay, Amer M. Zeidan, Rami S. Komrokji, Valeria Santini, Torsten Haferlach, Ulrich Germing, Saverio D'Amico, Gastone Castellani, Mrinal M. Patnaik, Eric Solary, Eric Padron, Matteo Giovanni Della Porta

Blood (2024) 144 (Supplement 1): 1003.

https://doi.org/10.1182/blood-2024-200104

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

MDS without clonal marker: When depth outperforms breadth

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

The PDI-ATF6-axis as a novel treatment target in CSF3R driven chronic neutrophilic leukemia (CNL)

Spatiotemporal and genetic tracking of long-term persisting CAR-T cells following ciltacabtagene autoleucel treatment for multiple myeloma reveals molecular insights into late-onset toxicities

CLL with t(11;14)(q13;q32) or t(14:18)(q32:q21) – is this CLL or lymphoma?

Activation of endogenous retroviral elements drives inflammation and transformation in STAG2-mutant myeloid malignancies

Enrichment of rare pathogenic variants in common cancer predisposition genes in lymphatic malignancy: A comprehensive analysis of 2,138 cases

Determining the origin of TP53 mutations in patients with mature B-cell neoplasms is essential to distinguish lymphoma-related mutations from those due to clonal hematopoiesis, helping to guide treatment decisions

Additional genetic targets are present in the majority of AML patients with NPM1, KMT2A or NUP98 aberrations potentially impacting combination therapy with menin inhibitors

Modeling of a hyper-inflammatory hematopoietic niche ex vivo reveals a multi-step process driving CAR T- cell associated myeloid leukemia in multiple myeloma

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

The role of sole loss of chromosome y in myeloid neoplasms

Determining telomere content and genomics of myeloid neoplasia by whole-genome sequencing

Impact of Molecular Aberrations on Discordance Among Modalities of Blast Enumeration for Risk Stratification in Myelodysplastic Neoplasms

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Subtype Classification of BCP-ALL Dic(9;20)

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

Newly Developed Prognostic Score for Myelodysplastic Syndrome (MDS) with Isolated 5q Deletion (IPSS-del(5q))

A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only